Spironolactone versus Bicalutamide in female pattern hair loss: A randomised clinical trial
Bicalutamide produced greater trichoscopic improvements than spironolactone; however, no significance between-group differences were observed in clinical endpoints. Limitations include a short follow-up period, single-centre design and per-protocol analysis, which may limit generalizability.
Authors
- Abhijeet Kumar Jha (ORCID: https://orcid.org/0000-0001-6010-3771)
- DR. A. D. Singh
- Md Zeeshan
- Balachandra S Ankad
Institutions
- Patna Medical College and Hospital (IN)
- S Nijalingappa Medical College and HSK Hospital & Research Centre (IN)
Publication Details
- Journal
- Clinical and Experimental Dermatology
- Published
- 2026-02-24
- DOI
- https://doi.org/10.1093/ced/llag099
- Primary Topic
- Hair Growth and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00